Fig. 1 · Structure

Documents & Downloads

Prednisolone acetate

Cat. No. A11687 CAS 52-21-1
Prednisolone is a synthetic glucocorticoid, a derivative of cortisol, which is used to treat a variety of inflammatory and auto-immune conditions.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Prednisolone acetate Research Summary

This section summarizes 2 in vivo studies of Prednisolone acetate from 1 published reference.

Prednisolone acetate In Vivo Studies

In Wistar rats with ALI, intraperitoneally injected Prednisolone acetate at 70 mg/kg markedly reduced serum CO2 concentration compared with the model group. In the histopathology study, Prednisolone acetate ameliorated lung injuries and reduced the severity of pulmonary inflammation compared with the model. [1]

Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.

Serum CO2 Reduction in ALI Rats

Animal study · Wistar rats (280-300 g); ALI rats [1]

In Wistar rats with ALI, Prednisolone acetate was injected intraperitoneally at 70 mg/kg. Serum CO2 concentration was markedly reduced compared with the model group.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
serum concentration of CO2Reported result prednisolone acetate (70 mg/kg) markedly reduced the concentration of CO2 as compared with model group (P<0.05).[1]

Conditions shared by the study groups

Route
injected intraperitoneally
Treatment course
30 min after the starting of resuscitation
Study groups and reported outcomes
Group / doseComparatorObserved resultReference
Prednisolone acetate 70 mg/kgmodel groupprednisolone acetate (70 mg/kg) markedly reduced the concentration of CO2 as compared with model group (P<0.05).[1]
Prednisolone acetate 70 mg/kg
Model: Wistar rats (280-300 g); ALI rats
Reported limits: Not stated in the sentences used: vehicle.
Methods and source locations

Compound reported in the paper: Prednisolone acetate

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

Materials and Methods > Animals (S15); Materials and Methods > Rat model of ALI (S57, S60, S63, S65, S66, S67); Results > Alleviation of inflammation by BPs in ALI model of rats (S120, S121); Figure 6 legend (S149)

serum concentration of CO2: serum concentration of CO2; comparator: model group — Results > Alleviation of inflammation by BPs in ALI model of rats (S120); Figure 6 legend (S149)

Prednisolone acetate 70 mg/kg · Materials and Methods > Rat model of ALI (S57, S60, S66); Results > Alleviation of inflammation by BPs in ALI model of rats (S120)

Lung Histopathology Improvement in ALI Rats

Animal study · Wistar rats (280-300 g); ALI rats [1]

In Wistar rats with ALI, Prednisolone acetate was injected intraperitoneally at 70 mg/kg. Compared with the model, treatment ameliorated lung injuries, with reduced severity of pulmonary inflammation.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
Histopathology findingsReported result prednisolone acetate (70 mg/kg) obviously ameliorated the lung injuries, which demonstrated a reduction in the severity of pulmonary inflammation.[1]

Conditions shared by the study groups

Route
injected intraperitoneally
Treatment course
30 min after the starting of resuscitation; 2.5 h after inhalation of saline or LPS
Study groups and reported outcomes
Group / doseComparatorObserved resultReference
Prednisolone acetate 70 mg/kgmodelprednisolone acetate (70 mg/kg) obviously ameliorated the lung injuries, which demonstrated a reduction in the severity of pulmonary inflammation.[1]
Prednisolone acetate 70 mg/kg
Model: Wistar rats (280-300 g); ALI rats
Reported limits: Not stated in the sentences used: vehicle.
Methods and source locations

Compound reported in the paper: Prednisolone acetate

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

Materials and Methods > Animals (S15); Materials and Methods > Rat model of ALI (S57, S60, S63, S65, S66, S67, S71); Results > Alleviation of inflammation by BPs in ALI model of rats (S121, S123); Figure 7 legend (S151)

Histopathology findings: Histopathology findings; comparator: model — Materials and Methods > Rat model of ALI (S57); Results > Alleviation of inflammation by BPs in ALI model of rats (S123); Figure 7 legend (S151)

Prednisolone acetate 70 mg/kg · Materials and Methods > Rat model of ALI (S57, S60, S66); Results > Alleviation of inflammation by BPs in ALI model of rats (S123); Figure 7 legend (S151)

Specifications

Manufacturer Adooq Bioscience
CAS Number 52-21-1
Formula C23H30O6
Molecular Weight 402.48
Synonyms Prednisolone-21-acetate; Omnipred
SMILES
CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)O)C)O

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 71 mg/mL (176.4 mM)
Water Insoluble
Ethanol Insoluble

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

In Vivo Preparation

Concentration
4 mg/mL
Vehicle
2% DMSO+30% PEG 300+2% Tween 80+ddH2O

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Prednisolone acetate Research References

  1. [1] Wu J, Zhang YY, Guo L, et al. Bupleurum polysaccharides attenuates lipopolysaccharide-induced inflammation via modulating Toll-like receptor 4 signaling. PLoS One (2013). PMID: 24167596 DOI: 10.1371/journal.pone.0078051 Source material

Added to your cart

View Cart Checkout
Loading...